Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials.
Identifieur interne : 000C89 ( PubMed/Curation ); précédent : 000C88; suivant : 000C90Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials.
Auteurs : Carlos M. Campos [Brésil] ; Adriano Caixeta [Brésil] ; Marcelo Franken [Brésil] ; Antonio L. Bartorelli [Italie] ; Robert J. Whitbourn [Australie] ; Chiung-Jen Wu [Taïwan] ; Hsien Li Paul Kao [Taïwan] ; Mohd Ali Rosli [Malaisie] ; Didier Carrie [France] ; Bernard De Bruyne [Belgique] ; Gregg W. Stone [États-Unis] ; Patrick W. Serruys [Royaume-Uni] ; Alexandre Abizaid [Brésil]Source :
- Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [ 1522-726X ] ; 2017.
Abstract
to compare the occurrence of clinical events in diabetics treated with the Absorb bioresorbable vascular scaffold (Absorb BVS; Abbott Vascular, Santa Clara, CA) versus everolimus-eluting metal stents (EES; XIENCE V; Abbott Vascular, Santa Clara, CA) BACKGROUND: There are limited data dedicated to clinical outcomes of diabetic patients treated with bioresorbable scaffolds (BRS) at 2-year horizon.
DOI: 10.1002/ccd.27109
PubMed: 28471086
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C92
Links to Exploration step
pubmed:28471086Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials.</title><author><name sortKey="Campos, Carlos M" sort="Campos, Carlos M" uniqKey="Campos C" first="Carlos M" last="Campos">Carlos M. Campos</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo</wicri:regionArea></affiliation></author><author><name sortKey="Caixeta, Adriano" sort="Caixeta, Adriano" uniqKey="Caixeta A" first="Adriano" last="Caixeta">Adriano Caixeta</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo</wicri:regionArea></affiliation></author><author><name sortKey="Franken, Marcelo" sort="Franken, Marcelo" uniqKey="Franken M" first="Marcelo" last="Franken">Marcelo Franken</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo</wicri:regionArea></affiliation></author><author><name sortKey="Bartorelli, Antonio L" sort="Bartorelli, Antonio L" uniqKey="Bartorelli A" first="Antonio L" last="Bartorelli">Antonio L. Bartorelli</name><affiliation wicri:level="1"><nlm:affiliation>Centro Cardiologico Monzino, IRCCS, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Centro Cardiologico Monzino, IRCCS, Milan</wicri:regionArea></affiliation></author><author><name sortKey="Whitbourn, Robert J" sort="Whitbourn, Robert J" uniqKey="Whitbourn R" first="Robert J" last="Whitbourn">Robert J. Whitbourn</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, St Vincent's Hospital, Fitzroy, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Cardiology, St Vincent's Hospital, Fitzroy, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Wu, Chiung Jen" sort="Wu, Chiung Jen" uniqKey="Wu C" first="Chiung-Jen" last="Wu">Chiung-Jen Wu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Chang Gung Memorial Hospital, Niao-Sung Hsiang, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Cardiology, Chang Gung Memorial Hospital, Niao-Sung Hsiang</wicri:regionArea></affiliation></author><author><name sortKey="Li Paul Kao, Hsien" sort="Li Paul Kao, Hsien" uniqKey="Li Paul Kao H" first="Hsien" last="Li Paul Kao">Hsien Li Paul Kao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, National Taiwan University Hospital, Taipei, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Cardiology, National Taiwan University Hospital, Taipei</wicri:regionArea></affiliation></author><author><name sortKey="Rosli, Mohd Ali" sort="Rosli, Mohd Ali" uniqKey="Rosli M" first="Mohd Ali" last="Rosli">Mohd Ali Rosli</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Institute Jantung Negara, Kuala Lumpur, Malaysia.</nlm:affiliation><country xml:lang="fr">Malaisie</country><wicri:regionArea>Department of Cardiology, Institute Jantung Negara, Kuala Lumpur</wicri:regionArea></affiliation></author><author><name sortKey="Carrie, Didier" sort="Carrie, Didier" uniqKey="Carrie D" first="Didier" last="Carrie">Didier Carrie</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Hôpital de Rangueil CHU, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Cardiology, Hôpital de Rangueil CHU, Toulouse</wicri:regionArea></affiliation></author><author><name sortKey="De Bruyne, Bernard" sort="De Bruyne, Bernard" uniqKey="De Bruyne B" first="Bernard" last="De Bruyne">Bernard De Bruyne</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Cardiovascular Center Aalst, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Cardiology, Cardiovascular Center Aalst</wicri:regionArea></affiliation></author><author><name sortKey="Stone, Gregg W" sort="Stone, Gregg W" uniqKey="Stone G" first="Gregg W" last="Stone">Gregg W. Stone</name><affiliation wicri:level="2"><nlm:affiliation>Department of Interventional Cardiology, Columbia University Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Interventional Cardiology, Columbia University Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W" last="Serruys">Patrick W. Serruys</name><affiliation wicri:level="1"><nlm:affiliation>International Centre for Circulatory Health, NHLI, Imperial College London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>International Centre for Circulatory Health, NHLI, Imperial College London</wicri:regionArea></affiliation></author><author><name sortKey="Abizaid, Alexandre" sort="Abizaid, Alexandre" uniqKey="Abizaid A" first="Alexandre" last="Abizaid">Alexandre Abizaid</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Interventional Cardiology, Instituto Dante Pazzanese de Cardiologia, São Paulo</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28471086</idno><idno type="pmid">28471086</idno><idno type="doi">10.1002/ccd.27109</idno><idno type="wicri:Area/PubMed/Corpus">000C92</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C92</idno><idno type="wicri:Area/PubMed/Curation">000C89</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C89</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials.</title><author><name sortKey="Campos, Carlos M" sort="Campos, Carlos M" uniqKey="Campos C" first="Carlos M" last="Campos">Carlos M. Campos</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo</wicri:regionArea></affiliation></author><author><name sortKey="Caixeta, Adriano" sort="Caixeta, Adriano" uniqKey="Caixeta A" first="Adriano" last="Caixeta">Adriano Caixeta</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo</wicri:regionArea></affiliation></author><author><name sortKey="Franken, Marcelo" sort="Franken, Marcelo" uniqKey="Franken M" first="Marcelo" last="Franken">Marcelo Franken</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo</wicri:regionArea></affiliation></author><author><name sortKey="Bartorelli, Antonio L" sort="Bartorelli, Antonio L" uniqKey="Bartorelli A" first="Antonio L" last="Bartorelli">Antonio L. Bartorelli</name><affiliation wicri:level="1"><nlm:affiliation>Centro Cardiologico Monzino, IRCCS, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Centro Cardiologico Monzino, IRCCS, Milan</wicri:regionArea></affiliation></author><author><name sortKey="Whitbourn, Robert J" sort="Whitbourn, Robert J" uniqKey="Whitbourn R" first="Robert J" last="Whitbourn">Robert J. Whitbourn</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, St Vincent's Hospital, Fitzroy, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Cardiology, St Vincent's Hospital, Fitzroy, Victoria</wicri:regionArea></affiliation></author><author><name sortKey="Wu, Chiung Jen" sort="Wu, Chiung Jen" uniqKey="Wu C" first="Chiung-Jen" last="Wu">Chiung-Jen Wu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Chang Gung Memorial Hospital, Niao-Sung Hsiang, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Cardiology, Chang Gung Memorial Hospital, Niao-Sung Hsiang</wicri:regionArea></affiliation></author><author><name sortKey="Li Paul Kao, Hsien" sort="Li Paul Kao, Hsien" uniqKey="Li Paul Kao H" first="Hsien" last="Li Paul Kao">Hsien Li Paul Kao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, National Taiwan University Hospital, Taipei, Taiwan.</nlm:affiliation><country xml:lang="fr">Taïwan</country><wicri:regionArea>Department of Cardiology, National Taiwan University Hospital, Taipei</wicri:regionArea></affiliation></author><author><name sortKey="Rosli, Mohd Ali" sort="Rosli, Mohd Ali" uniqKey="Rosli M" first="Mohd Ali" last="Rosli">Mohd Ali Rosli</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Institute Jantung Negara, Kuala Lumpur, Malaysia.</nlm:affiliation><country xml:lang="fr">Malaisie</country><wicri:regionArea>Department of Cardiology, Institute Jantung Negara, Kuala Lumpur</wicri:regionArea></affiliation></author><author><name sortKey="Carrie, Didier" sort="Carrie, Didier" uniqKey="Carrie D" first="Didier" last="Carrie">Didier Carrie</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Hôpital de Rangueil CHU, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Cardiology, Hôpital de Rangueil CHU, Toulouse</wicri:regionArea></affiliation></author><author><name sortKey="De Bruyne, Bernard" sort="De Bruyne, Bernard" uniqKey="De Bruyne B" first="Bernard" last="De Bruyne">Bernard De Bruyne</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Cardiovascular Center Aalst, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Cardiology, Cardiovascular Center Aalst</wicri:regionArea></affiliation></author><author><name sortKey="Stone, Gregg W" sort="Stone, Gregg W" uniqKey="Stone G" first="Gregg W" last="Stone">Gregg W. Stone</name><affiliation wicri:level="2"><nlm:affiliation>Department of Interventional Cardiology, Columbia University Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Interventional Cardiology, Columbia University Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Serruys, Patrick W" sort="Serruys, Patrick W" uniqKey="Serruys P" first="Patrick W" last="Serruys">Patrick W. Serruys</name><affiliation wicri:level="1"><nlm:affiliation>International Centre for Circulatory Health, NHLI, Imperial College London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>International Centre for Circulatory Health, NHLI, Imperial College London</wicri:regionArea></affiliation></author><author><name sortKey="Abizaid, Alexandre" sort="Abizaid, Alexandre" uniqKey="Abizaid A" first="Alexandre" last="Abizaid">Alexandre Abizaid</name><affiliation wicri:level="1"><nlm:affiliation>Department of Interventional Cardiology, Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.</nlm:affiliation><country xml:lang="fr">Brésil</country><wicri:regionArea>Department of Interventional Cardiology, Instituto Dante Pazzanese de Cardiologia, São Paulo</wicri:regionArea></affiliation></author></analytic><series><title level="j">Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions</title><idno type="eISSN">1522-726X</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">to compare the occurrence of clinical events in diabetics treated with the Absorb bioresorbable vascular scaffold (Absorb BVS; Abbott Vascular, Santa Clara, CA) versus everolimus-eluting metal stents (EES; XIENCE V; Abbott Vascular, Santa Clara, CA) BACKGROUND: There are limited data dedicated to clinical outcomes of diabetic patients treated with bioresorbable scaffolds (BRS) at 2-year horizon.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">28471086</PMID><DateCreated><Year>2017</Year><Month>05</Month><Day>04</Day></DateCreated><DateRevised><Year>2017</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-726X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2017</Year><Month>May</Month><Day>04</Day></PubDate></JournalIssue><Title>Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions</Title><ISOAbbreviation>Catheter Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/ccd.27109</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">to compare the occurrence of clinical events in diabetics treated with the Absorb bioresorbable vascular scaffold (Absorb BVS; Abbott Vascular, Santa Clara, CA) versus everolimus-eluting metal stents (EES; XIENCE V; Abbott Vascular, Santa Clara, CA) BACKGROUND: There are limited data dedicated to clinical outcomes of diabetic patients treated with bioresorbable scaffolds (BRS) at 2-year horizon.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The present study included 812 patients in the ABSORB EXTEND study in which a total of 215 diabetic patients were treated with Absorb BVS. In addition, 882 diabetic patients treated with EES in pooled data from the SPIRIT clinical program (SPIRIT II, SPIRIT III and SPIRIT IV trials) were used for comparison by applying propensity score matching using 29 different variables. The primary endpoint was ischemia driven major adverse cardiac events (ID-MACE), including cardiac death, myocardial infarction (MI), and ischemia driven target lesion revascularization (ID-TLR).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After 2 years, the ID-MACE rate was 6.5% in the Absorb BVS vs. 8.9% in the Xience group (P = 0.40). There was no difference for MACE components or definite/probable device thrombosis (HR: 1.43 [0.24,8.58]; P = 0.69). The occurrence of MACE was not different for both diabetic status (insulin- and non-insulin-requiring diabetes) in all time points up to the 2-year follow-up for the Absorb and Xience groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this largest ever patient-level pooled comparison on the treatment of diabetic patients with BRS out to two years, individuals with diabetes treated with the Absorb BVS had a similar rate of MACE as compared with diabetics treated with the Xience EES. © 2017 Wiley Periodicals, Inc.</AbstractText><CopyrightInformation>© 2017 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Carlos M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1734-6924</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caixeta</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franken</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartorelli</LastName><ForeName>Antonio L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Centro Cardiologico Monzino, IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitbourn</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, St Vincent's Hospital, Fitzroy, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chiung-Jen</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chang Gung Memorial Hospital, Niao-Sung Hsiang, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li Paul Kao</LastName><ForeName>Hsien</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosli</LastName><ForeName>Mohd Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Institute Jantung Negara, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrie</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hôpital de Rangueil CHU, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Bruyne</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center Aalst, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Gregg W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Columbia University Medical Center, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Foundation, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serruys</LastName><ForeName>Patrick W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>International Centre for Circulatory Health, NHLI, Imperial College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abizaid</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ABSORB Cohort B and the SPIRIT II, III, and IV Investigators.</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Catheter Cardiovasc Interv</MedlineTA><NlmUniqueID>100884139</NlmUniqueID><ISSNLinking>1522-1946</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DES-stent</Keyword><Keyword MajorTopicYN="N">bioabsorbable devices/polymers</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">drug eluting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>03</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28471086</ArticleId><ArticleId IdType="doi">10.1002/ccd.27109</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C89 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000C89 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:28471086
|texte= Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:28471086" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |